Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
2001 1
2005 1
2012 1
2013 1
2015 1
2016 1
2017 2
2019 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA; ARIEL3 investigators. Coleman RL, et al. Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12. Lancet. 2017. PMID: 28916367 Free PMC article. Clinical Trial.
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators. Oza AM, et al. Lancet Oncol. 2015 Aug;16(8):928-36. doi: 10.1016/S1470-2045(15)00086-8. Epub 2015 Jun 23. Lancet Oncol. 2015. PMID: 26115797 Free PMC article. Clinical Trial.
Mirror Switching for High-Resolution Ion Isolation in an Electrostatic Linear Ion Trap.
Johnson JT, Carrick IJ, Eakins GS, McLuckey SA. Johnson JT, et al. Anal Chem. 2019 Jul 16;91(14):8789-8794. doi: 10.1021/acs.analchem.9b00874. Epub 2019 Jun 27. Anal Chem. 2019. PMID: 31246434
Ion isolation was achieved via selective pulsing of the entrance and exit ion mirrors in an electrostatic linear ion trap mass spectrometer (ELIT). Mirror switching has been described previously as a method for capturing injected ions in ELIT devices. ...As isolatio …
Ion isolation was achieved via selective pulsing of the entrance and exit ion mirrors in an electrostatic linear ion trap mass spectrometer …
Palliative chemotherapy for malignant ascites secondary to ovarian cancer.
Malayev Y, Levene R, Gonzalez F. Malayev Y, et al. Am J Hosp Palliat Care. 2012 Nov;29(7):515-21. doi: 10.1177/1049909111434044. Epub 2012 Feb 23. Am J Hosp Palliat Care. 2012. PMID: 22363037 Review.
.), other studies show aggressive end-of-life treatment adversely affects quality of life and shortens life span (Arriba L, Fader A, Frasure H, von Gruenigen V. A review of issues surrounding quality of life among women with ovarian cancer. ...Without a consensus on pallia …
.), other studies show aggressive end-of-life treatment adversely affects quality of life and shortens life span (Arriba L, Fader A, …
Phenolic acids, syringaldehyde, and juglone in fruits of different cultivars of Juglans regia L.
Colaric M, Veberic R, Solar A, Hudina M, Stampar F. Colaric M, et al. J Agric Food Chem. 2005 Aug 10;53(16):6390-6. doi: 10.1021/jf050721n. J Agric Food Chem. 2005. PMID: 16076123
Phenolic acids (chlorogenic, caffeic, p-coumaric, ferulic, sinapic, ellagic, and syringic acid) as well as syringaldehyde and juglone were identified in ripe fruits of 10 walnut cultivars: Adams, Cisco, Chandler, Franquette, Lara, Fernor, Fernette, Alsoszentivani 117 (A-117), Ras …
Phenolic acids (chlorogenic, caffeic, p-coumaric, ferulic, sinapic, ellagic, and syringic acid) as well as syringaldehyde and juglone were i …
Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes.
Scott SA, Llaurado Fernandez M, Kim H, Elit L, Nourmoussavi M, Glaze S, Roberts L, Offman SL, Rahimi K, Lytwyn A, Sur M, Gilks CB, Matheson K, Köbel M, Dawson A, Tinker AV, Kwon JS, Hoskins P, Santos JL, Cheung A, Provencher D, Carey MS; Canadian LGSC Community of Practice (GOC-CoP). Scott SA, et al. Gynecol Oncol. 2020 Apr;157(1):36-45. doi: 10.1016/j.ygyno.2020.01.021. Epub 2020 Jan 27. Gynecol Oncol. 2020. PMID: 32001076
Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
Kwon JS, Elit L, Mazurka J, Moens F, Schmuck ML. Kwon JS, et al. Gynecol Oncol. 2001 Aug;82(2):367-70. doi: 10.1006/gyno.2001.6271. Gynecol Oncol. 2001. PMID: 11531296
Complete response was defined as the attainment of a serum beta-hCG level <5 IU/L for 3 consecutive weeks. Toxicity was graded according to the National Cancer Institute of Canada-Clinical Trials Group criteria for chemotherapy toxicity. ...
Complete response was defined as the attainment of a serum beta-hCG level <5 IU/L for 3 consecutive weeks. Toxicity was graded acc …
International challenge to predict the impact of radioxenon releases from medical isotope production on a comprehensive nuclear test ban treaty sampling station.
Eslinger PW, Bowyer TW, Achim P, Chai T, Deconninck B, Freeman K, Generoso S, Hayes P, Heidmann V, Hoffman I, Kijima Y, Krysta M, Malo A, Maurer C, Ngan F, Robins P, Ross JO, Saunier O, Schlosser C, Schöppner M, Schrom BT, Seibert P, Stein AF, Ungar K, Yi J. Eslinger PW, et al. J Environ Radioact. 2016 Jun;157:41-51. doi: 10.1016/j.jenvrad.2016.03.001. Epub 2016 Mar 19. J Environ Radioact. 2016. PMID: 26998569
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page